Erudio Healtherudio.com
Drug
Binimetinib trials: what clinicians said in public
An HCP commentary report on 1 clinical trial studying binimetinib: ENCO-BRAF. It covers what clinicians said in public about one trial, on podcasts, videos and posts, every statement linked to its source. Below them, 4 more trials with public commentary and no report yet.
| Trial | Indication | Phase | Statements | Sources | Size | Checked | Preview |
|---|---|---|---|---|---|---|---|
| ENCO-BRAF NCT04526782 · Intergroupe Francophone de Cancerologie Thoracique | BRAF V600E-mutant metastatic non-small cell lung cancer | Phase 2 | 30 | 17 | Focused | Nov 21, 2026 | Preview |
| No report yetTrials with public commentary we haven't built a report for. Size is an estimate of the verified statements the commentary we've indexed so far will yield; final coverage is set when we build the report, within 24 hours of your confirmed order. You never pay more than quoted: a report delivered at a smaller size costs that size's price. Some can also be requested as a free preview. | |||||||
| PHAROS NCT03915951 · Pfizer DeepView → | BRAF V600E-mutant metastatic non-small cell lung cancer | Phase 2 | Deep | View | |||
| BEACON CRC NCT02928224 · Pfizer DeepView → | BRAF V600E-mutant metastatic colorectal cancer | Phase 3 | Deep | View | |||
| ANCHOR CRC NCT03693170 · Pierre Fabre Medicament StandardView → | previously untreated BRAF V600E-mutant metastatic colorectal cancer | Phase 2 | Standard | View | |||
| NCT04292119 NCT04292119 · Massachusetts General Hospital FocusedView → | anaplastic lymphoma kinase-rearranged lung cancer | Phase 1/Phase 2 | Focused | View | |||